Mr. Michels brings to the Board more than 30 years of experience in the healthcare diagnostics industry, including service as Chief Executive Officer of OraSure Technologies (2004 2018) and earlier roles at Johnson & Johnson (1985 2004). At OraSure, he oversaw the development and FDA approval of the nation s first over-the-counter rapid HIV self-test and the first and only FDA-approved rapid hepatitis C test. His experience leading global operations and navigating complex regulatory processes provides the Board with valuable insight into risk management, compliance and innovation oversight. Mr. Michels background in strategy, supply-chain management and product development supports his service on the Audit and Nominating & Corporate Governance Committees.